These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 7191052)

  • 41. Effects of nifedipine on left ventricular diastolic function in patients with asymptomatic or minimally symptomatic hypertrophic cardiomyopathy.
    Yamakado T; Okano H; Higashiyama S; Hamada M; Nakano T; Takezawa H
    Circulation; 1990 Feb; 81(2):593-601. PubMed ID: 2297865
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Increased sensitivity of left ventricular relaxation to inotropic interventions in patients with coronary artery disease: comparison with normal subjects, mitral stenosis and asymmetric septal hypertrophy.
    Rousseau MF; Pouleur H; Detry JM; Brasseur LA
    Eur Heart J; 1980 Dec; 1(Suppl B):37-41. PubMed ID: 6291944
    [No Abstract]   [Full Text] [Related]  

  • 43. [Effect of diltiazem on left ventricular function in hypertrophic cardiomyopathy].
    Zhu JR; Li ZS; Zhao HY
    Zhonghua Nei Ke Za Zhi; 1986 Oct; 25(10):584-6, 636. PubMed ID: 3568837
    [No Abstract]   [Full Text] [Related]  

  • 44. Relation between serum nifedipine concentration and hemodynamic effects in nonobstructive hypertrophic cardiomyopathy.
    Betocchi S; Bonow RO; Cannon RO; Lesko LJ; Ostrow HG; Watson RM; Rosing DR
    Am J Cardiol; 1988 Apr; 61(10):830-5. PubMed ID: 3354448
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Effect of propranolol on left ventricular relaxation in hypertrophic cardiomyopathy: an echographic study.
    Bourmayan C; Razavi A; Fournier C; Dussaule JC; Baragan J; Gerbaux A; Gay J
    Am Heart J; 1985 Jun; 109(6):1311-6. PubMed ID: 4039882
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Adverse effects of nifedipine therapy on hypertrophic obstructive cardiomyopathy.
    Fedor JM; Stack RS; Pryor DB; Phillips HR
    Chest; 1983 Apr; 83(4):704-6. PubMed ID: 6682029
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Diltiazem-induced decrease of exercise-elevated pulmonary arterial diastolic pressure in hypertrophic cardiomyopathy patients.
    Nagao M; Yasue H; Omote S; Takizawa A; Hyon H; Nishida S; Horie M; Yamada K; Tanaka S
    Am Heart J; 1981 Oct; 102(4):789-90. PubMed ID: 7197114
    [No Abstract]   [Full Text] [Related]  

  • 48. [Echocardiographic study of AV function in primary cardiomyopathy].
    Yang Q
    Zhonghua Xin Xue Guan Bing Za Zhi; 1985 Sep; 13(4):270-2. PubMed ID: 3836885
    [No Abstract]   [Full Text] [Related]  

  • 49. Diastolic movement of mitral valve in hypertrophic cardiomyopathy. An echocardiographic study.
    Venco A; Recusani F; Sgalambro A
    Br Heart J; 1980 Feb; 43(2):159-63. PubMed ID: 7189121
    [No Abstract]   [Full Text] [Related]  

  • 50. Invasive Hemodynamics of Myocardial Disease: Systolic and Diastolic Dysfunction (and Hypertrophic Obstructive Cardiomyopathy).
    Eskander M; Kern MJ
    Interv Cardiol Clin; 2017 Jul; 6(3):297-307. PubMed ID: 28600085
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [Changes in the intracardiac hemodynamics of patients with essential hypertension during korinfar treatment].
    Sakharchuk II; Gol'denberg GM; Bobrova EV
    Lik Sprava; 1993; (2-3):118-20. PubMed ID: 8191707
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [Effects of inotropic drugs on the indices of systolic time intervals and diastolic time intervals (author's transl)].
    Wu BW; LI L; Zhao RR
    Zhonghua Xin Xue Guan Bing Za Zhi; 1979; 7(4):283-6. PubMed ID: 553027
    [No Abstract]   [Full Text] [Related]  

  • 53. [Systolic and diastolic time intervals and mean toxic doses of ethanol].
    Kollár J; Cerenský M; Bodnár S; Bartok D; Berc A
    Bratisl Lek Listy; 1980 Mar; 73(3):339-40. PubMed ID: 7363129
    [No Abstract]   [Full Text] [Related]  

  • 54. The effect of nifedipine on the isolated rat heart.
    Refsum H; Glomstein A; Landmark K
    Acta Pharmacol Toxicol (Copenh); 1976 Apr; 38(4):326-35. PubMed ID: 946731
    [No Abstract]   [Full Text] [Related]  

  • 55. [Effect of verapamil on left ventricular function in patients with hypertrophic cardiomyopathy].
    Zhao ZL
    Zhonghua Nei Ke Za Zhi; 1983 Jul; 22(7):439-41. PubMed ID: 6685611
    [No Abstract]   [Full Text] [Related]  

  • 56. Diastolic dysfunction in hypertrophic cardiomyopathy. Effect on active force generation during systole.
    Gwathmey JK; Warren SE; Briggs GM; Copelas L; Feldman MD; Phillips PJ; Callahan M; Schoen FJ; Grossman W; Morgan JP
    J Clin Invest; 1991 Mar; 87(3):1023-31. PubMed ID: 1999483
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Effects of atropine on diastolic time.
    Conrad KA
    Circulation; 1981 Feb; 63(2):371-7. PubMed ID: 7449059
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [Usefulness of the evaluation of the diastolic function with echopolygraphy and radioisotopic angiography in hypertrophic cardiomyopathy].
    Gianfagna P; Vanuzzo D; Proclemer A; Geatti O; Cattaruzzi E; Feruglio GA
    Minerva Cardioangiol; 1988 Oct; 36(10):529-40. PubMed ID: 3226566
    [No Abstract]   [Full Text] [Related]  

  • 59. Effects of disopyramide on diastolic function in hypertrophic cardiomyopathy.
    Pollick C
    Am J Cardiol; 1995 Mar; 75(8):652. PubMed ID: 7734026
    [No Abstract]   [Full Text] [Related]  

  • 60. [Age-related characteristics of a change in cardiac systolic and diastolic functions under the influence of the adrenergic stimulants isadrin and mezaton (based on data from a computer analysis of the echocardiogram)].
    Korkushko OV; Moroz GZ
    Kardiologiia; 1988 Aug; 28(8):97-9. PubMed ID: 3199664
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.